Bruker Corp. (NASDAQ:BRKR) said it plans to ask for a stay and appeal a ruling on an injunction that will block the sale of NanoString's GeoMX products in the U.S. “We respectfully disagree with the ...
A top European court ruled against Harvard last week in a patent dispute against biotech company NanoString Technologies, invalidating one of the University’s two disputed patents in three European ...
PLEASANTON, Calif., Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S.
* NANOSTRING TECHNOLOGIES-TO USE ABOUT $89.0 MILLION OF NET PROCEEDS TO PREPAY AMOUNTS BORROWED, FEES OWING RELATED TO TERMINATION OF SENIOR TERM LOAN FACILITY * NANOSTRING-TO USE ABOUT $89.0 MILLION ...
BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensive solutions for ...
10X Genomics (NASDAQ:TXG) won a permanent injunction against NanoString Technologies in a patent dispute. 10X Genomics rose 3.3%. A permanent injunction will be issued on Jan. 10, U.S. District Judge ...
* Nanostring technologies-under terms of deal, lam will provide up to $50 million of funding intended to cover costs of development and regulatory approval * Nanostring technologies inc - lam will ...
Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback